Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
63.98
-2.55 (-3.83%)
Nov 6, 2026, 4:00 PM EST - Market closed
Inspire Medical Systems Revenue
Inspire Medical Systems had revenue of $206.70M in the quarter ending September 30, 2026, a decrease of -7.93%. This brings the company's total for the last twelve months to $880.94M, down -0.19% year-over-year. In the year 2025, Inspire Medical Systems had annual revenue of $911.98M with 13.60% growth. That makes Inspire Medical Systems the 8,227th largest company in the world by revenue and 1,874th in the United States.
Revenue (ttm)
$880.94M
Revenue Growth
-0.19%
P/S Ratio
2.10
Revenue / Employee
$660,867
Employees
1,333
Market Cap
1.85B
Revenue by Geography
- United States 872.09M 95.6%
- All Other Countries 39.90M 4.4%
Fiscal year ended Dec 31, 2025 See the full Inspire Medical Systems breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 911.98M | 109.18M | 13.60% |
| Dec 31, 2024 | 802.80M | 178.01M | 28.49% |
| Dec 31, 2023 | 624.80M | 216.94M | 53.19% |
| Dec 31, 2022 | 407.86M | 174.46M | 74.75% |
| Dec 31, 2021 | 233.39M | 118.01M | 102.28% |
| Dec 31, 2020 | 115.38M | 33.33M | 40.62% |
| Dec 31, 2019 | 82.05M | 31.46M | 62.18% |
| Dec 31, 2018 | 50.59M | 22.03M | 77.10% |
| Dec 31, 2017 | 28.57M | 12.14M | 73.90% |
| Dec 31, 2016 | 16.43M | 8.42M | 105.03% |
| Dec 31, 2015 | 8.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.31B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.08B |
| Lumexa Imaging Holdings | 1.04B |
| Neogen | 884.00M |
| NovoCure | 725.39M |
| UFP Technologies | 649.52M |
| PROCEPT BioRobotics | 352.31M |
INSP News
- 17 hours ago - Inspire Medical price target raised to $45 from $40 at UBS - TheFly
- 3 days ago - Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference - GlobeNewsWire
- 3 days ago - Inspire Medical price target raised to $65 from $60 at JPMorgan - TheFly
- 3 days ago - Inspire Medical price target raised to $70 from $60 at Piper Sandler - TheFly
- 3 days ago - Inspire Medical price target raised to $69 from $56 at Wells Fargo - TheFly
- 3 days ago - Inspire Medical price target raised to $77 from $73 at Baird - TheFly
- 3 days ago - Inspire Medical price target lowered to $62 from $65 at Barclays - TheFly
- 4 days ago - Inspire Medical Systems Earnings Call Transcript: Q3 2026 - Transcripts